Search

Your search keyword '"Maluquer, Clara"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Maluquer, Clara" Remove constraint Author: "Maluquer, Clara"
41 results on '"Maluquer, Clara"'

Search Results

1. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

2. Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results

3. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

4. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

5. Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic

7. Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.

9. Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

10. Supplementary Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

11. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

12. Real-Life Experience of Use of Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia. a Single Center Experience

13. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

14. Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry

15. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

16. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

18. Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

20. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain

21. ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group

22. Poster: ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group

24. The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

25. Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

26. Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma

27. Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

28. Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

29. Clonal relationship in multisited mucosa‐associated lymphoid tissue lymphomas: a single‐centre experience

31. Clonal relationship in multisited mucosa‐associated lymphoid tissue lymphomas: a single‐centre experience.

36. sj-docx-1-tam-10.1177_17588359211042224 – Supplemental material for Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

37. sj-docx-1-tam-10.1177_17588359211042224 – Supplemental material for Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

38. Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials.

39. COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.

40. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.

41. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Catalog

Books, media, physical & digital resources